CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Ugo Testa(Istituto Superiore di Sanità), Arthur E. Frankel(The University of Texas Southwestern Medical Center)

Biomarker Research

February 10, 2014

10.1186/2050-7771-2-4

Cited by 249

Related Papers

The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

|Cell|1993|610

A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis

|Nature Cell Biology|2008|226

Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases

|European Respiratory Journal|2018|214

Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.

|The EMBO Journal|1996|128

BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin

|Molecular Cancer Therapeutics|2005|73